Social determinants of health linked to HIV mortality rates

March 19, 2018

TORONTO, March 19, 2018--People who are living with HIV in Ontario have access to good health care and medications, yet they are still dying younger and at substantially higher rates than the rest of the population, according to a new study published today.

The findings suggest that the overall well-being of these people is being negatively impacted by the social determinants of health--non-medical or non-genetic factors such as income, job status, education and housing, according to the study in the journal AIDS and Behaviour.

Led by Dr. Sean Rourke, a neuropsychologist at St. Michael's Hospital and scientist at its Centre for Urban Health Solutions, researchers followed 602 people with HIV recruited from community-based agencies for five years. People with HIV conducted peer-to-peer interviews with other HIV-positive people and then verified who was still alive at one, three and five years, using information, if necessary, obtained from relatives, partners, friends, obituaries and local AIDS memorial lists.

Of the 454 people whose mortality the researchers were able to confirm at the end of the study, 53 had died, which is the equivalent of 22.3 deaths per 100,000 people, substantially higher than the rate in the general population of 6.7 per 100,000 people. Seventy-three per cent of those who died were under 50.

People outside of Toronto died at even higher rates, especially in northern Ontario. (50 per cent outside the Greater Toronto area vs. 42 per cent inside the GTA.)

The study was dedicated to six peer-to-peer researchers who were among the 53 people who died.

The researchers found that 78 per cent of the study participants were unemployed, 68 per cent had an income under $12,000 a year, 42 per cent had a history of homelessness, and 31 per cent had a history of incarceration.

Individuals who died during the followup period were more likely to have less than high school education (36 per cent versus 20 per cent), be unemployed (89 per cent vs. 77 per cent), have a history of homelessness (57 per cent vs. 39 per cent,) or have a history of incarceration (58 per cent vs. 28 per cent.).

When the researchers divided the study participants by gay men, women and heterosexual men, they found that past incarcerations and homelessness were significant factors among gay men who died, along with poor self-rated health. Dr. Rourke noted that both homelessness and being incarcerated can have significant effects on a person's health and may even contribute to the progression of HIV, especially right after being incarcerated.

For women and heterosexual men, Caucasian ethnicity, history of incarceration and describing themselves as being in poor or fair health predicted an increased risk of mortality.

Across Canada, an estimated 75,500 people in Canada were living with HIV in 2014, the most recent year for which statistic are available. Due to advances in antiretroviral therapy, the number of deaths due to HIV infection declined by half between 1997 and 2011 and five-year survival rates among those diagnosed with AIDS increased from 7 per cent in 1981-1986 to 65 per cent in 1997-2012.

"Despite these incredible advances in science, we now need to pay much more attention to address the social and structural drivers affecting those living with HIV," said Dr. Rourke. "This means we need to address mental health and addiction issues, housing, social isolation and income supports, for example. We also need to make sure the health system is redesigned in ways to support access to co-ordinated patient centre care and services for people living with a chronic disease so that they are not only living healthier, but conditions are in place so that they can thrive into older age."
This study received funding from the Canadian Institutes of Health Research, the Ontario Ministry of Health and Long-Term Care, the Ontario AIDS Network, the Wellesley Institute and the Ontario HIV Treatment Network.

About St. Michael's Hospital

St. Michael's Hospital provides compassionate care to all who enter its doors. The hospital also provides outstanding medical education to future health care professionals in more than 29 academic disciplines. Critical care and trauma, heart disease, neurosurgery, diabetes, cancer care, and care of the homeless are among the Hospital's recognized areas of expertise. Through the Keenan Research Centre and the Li Ka Shing International Healthcare Education Center, which make up the Li Ka Shing Knowledge Institute, research and education at St. Michael's Hospital are recognized and make an impact around the world. Founded in 1892, the hospital is fully affiliated with the University of Toronto.

Media contact

For more information, or it interview Dr. Rourke, please contact:

Leslie Shepherd
Manager, Media Strategy
St. Michael's Hospital
Phone: 416-864-6094 or 416-200-4087

Follow us on Twitter:

St. Michael's Hospital

Related HIV Articles from Brightsurf:

BEAT-HIV Delaney collaboratory issues recommendations measuring persistent HIV reservoirs
Spearheaded by Wistar scientists, top worldwide HIV researchers from the BEAT-HIV Martin Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy (BEAT-HIV Collaboratory) compiled the first comprehensive set of recommendations on how to best measure the size of persistent HIV reservoirs during cure-directed clinical studies.

The Lancet HIV: Study suggests a second patient has been cured of HIV
A study of the second HIV patient to undergo successful stem cell transplantation from donors with a HIV-resistant gene, finds that there was no active viral infection in the patient's blood 30 months after they stopped anti-retroviral therapy, according to a case report published in The Lancet HIV journal and presented at CROI (Conference on Retroviruses and Opportunistic Infections).

Children with HIV score below HIV-negative peers in cognitive, motor function tests
Children who acquired HIV in utero or during birth or breastfeeding did not perform as well as their peers who do not have HIV on tests measuring cognitive ability, motor function and attention, according to a report published online today in Clinical Infectious Diseases.

Efforts to end the HIV epidemic must not ignore people already living with HIV
Efforts to prevent new HIV transmissions in the US must be accompanied by addressing HIV-associated comorbidities to improve the health of people already living with HIV, NIH experts assert in the third of a series of JAMA commentaries.

The Lancet HIV: Severe anti-LGBT legislations associated with lower testing and awareness of HIV in African countries
This first systematic review to investigate HIV testing, treatment and viral suppression in men who have sex with men in Africa finds that among the most recent studies (conducted after 2011) only half of men have been tested for HIV in the past 12 months.

The Lancet HIV: Tenfold increase in number of adolescents on HIV treatment in South Africa since 2010, but many still untreated
A new study of more than 700,000 one to 19-year olds being treated for HIV infection suggests a ten-fold increase in the number of adolescents aged 15 to 19 receiving HIV treatment in South Africa, according to results published in The Lancet HIV journal.

Starting HIV treatment in ERs may be key to ending HIV spread worldwide
In a follow-up study conducted in South Africa, Johns Hopkins Medicine researchers say they have evidence that hospital emergency departments (EDs) worldwide may be key strategic settings for curbing the spread of HIV infections in hard-to-reach populations if the EDs jump-start treatment and case management as well as diagnosis of the disease.

NIH HIV experts prioritize research to achieve sustained ART-free HIV remission
Achieving sustained remission of HIV without life-long antiretroviral therapy (ART) is a top HIV research priority, according to a new commentary in JAMA by experts at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

The Lancet HIV: PrEP implementation is associated with a rapid decline in new HIV infections
Study from Australia is the first to evaluate a population-level roll-out of pre-exposure prophylaxis (PrEP) in men who have sex with men.

Researchers date 'hibernating' HIV strains, advancing BC's leadership in HIV cure research
Researchers have developed a novel way for dating 'hibernating' HIV strains, in an advancement for HIV cure research.

Read More: HIV News and HIV Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to